Luong Hien D. How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?. JOVR [Internet]. 2020Oct.25 [cited 2024Apr.18];15(4):442–445. Available from: https://knepublishing.com/index.php/JOVR/article/view/7777
Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Palo Alto, California, USA; Pham Ngoc Thach University of Medicine, Saigon, Vietnam
Published Date
Oct 25, 2020
This journal is publishing all the articles under Creative Commons Attribution License CC BY 4.0.
How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?